Stride price target raised to $135 from $130 at Canaccord

Canaccord raised the firm’s price target on Stride (LRN) to $135 from $130 and keeps a Buy rating on the shares. The firm noted they reported strong fiscal 2Q25 results, with enrollment, revenue, and adjusted operating income all coming in well ahead of expectations. Enrollment momentum remains broad-based, with post-pandemic gains appearing structural given a third consecutive year of strong in-year demand, and more efficient marketing spend coupled with operating leverage resulted in continued margin expansion.